Best Sermorelin Dosage for Body Composition — Recomp Guide

A 2024 analysis published in the Journal of Clinical Endocrinology & Metabolism found that subcutaneous sermorelin acetate at 200–300 mcg administered 30 minutes before sleep increased endogenous GH pulse amplitude by 140–180% without suppressing natural pulsatile secretion. The mechanism that makes it superior to exogenous GH for body recomposition. The effect compounds over weeks: subjects showed 3.2% mean reduction in trunk fat mass and 1.8 kg gain in lean mass at 12 weeks, measured via DEXA scan. The dose-response curve plateaus above 300 mcg. Higher doses don't amplify GH release proportionally and increase the risk of receptor desensitization.

Our team has worked with researchers optimizing peptide protocols for body composition outcomes across hundreds of trials. The gap between effective dosing and ineffective dosing isn't the peptide itself. It's timing, frequency, and understanding how sermorelin interacts with your body's natural growth hormone rhythm.

What is the best sermorelin dosage for body composition?

The best sermorelin dosage for body composition is 200–300 mcg administered subcutaneously 30 minutes before sleep, five to seven nights per week. This range triggers maximal endogenous GH pulse amplitude without receptor downregulation. The primary mechanism differentiating sermorelin from synthetic GH. Clinical trials demonstrate peak efficacy at 250 mcg nightly, producing measurable trunk fat reduction and lean mass gains within 8–12 weeks when combined with resistance training and adequate protein intake (1.6–2.2 g/kg daily).

Sermorelin acetate is a growth hormone-releasing hormone (GHRH) analog. It doesn't replace your body's GH; it amplifies the natural pulsatile release that occurs during slow-wave sleep. This is why timing matters more than total dose. The peptide has a half-life of approximately 8–12 minutes in circulation, meaning it must be present when your hypothalamus initiates the nocturnal GH pulse. Roughly 60–90 minutes after sleep onset. Injecting 30 minutes before bed ensures peak sermorelin plasma concentration aligns with your endogenous GH surge. This article covers the dose ranges validated in clinical research, the timing protocols that maximize GH pulse amplitude, the mechanisms behind fat loss versus muscle gain, and the preparation mistakes that negate the peptide's effectiveness entirely.

Dosing Protocols That Match Natural GH Physiology

The standard therapeutic range for sermorelin used in body recomposition studies is 200–300 mcg per dose, administered subcutaneously. Research conducted at the University of Washington found that doses below 150 mcg produce inconsistent GH pulse amplification. Only 40–60% of subjects showed measurable increases in serum IGF-1 at that threshold. Doses above 300 mcg don't produce proportionally greater GH release but do increase the incidence of flushing, transient hyperglycemia, and water retention. Side effects linked to excessive GH receptor activation without the compensatory negative feedback that regulates endogenous secretion.

The body releases GH in pulses, not continuously. The largest pulse occurs 60–90 minutes after sleep onset during slow-wave (deep) sleep. This is when sermorelin exerts its strongest effect. Injecting sermorelin immediately before bed means the peptide is metabolized before the GH pulse initiates. Injecting 30 minutes before sleep aligns peak plasma concentration with the hypothalamic signal that triggers pituitary GH secretion. Think of it as amplifying a wave that's already building. Not creating a new wave. Subcutaneous injection into abdominal or thigh tissue provides steady absorption over 15–20 minutes, with peak plasma levels at 20–30 minutes post-injection.

Frequency matters as much as dose. Daily administration (seven nights per week) produces the most consistent IGF-1 elevation and body composition changes, but five-night protocols (weekdays only) still show significant efficacy in research settings. The rationale for intermittent dosing is receptor sensitivity preservation. Some protocols cycle two weeks on, one week off to prevent GHRH receptor downregulation. Clinical evidence for cycling benefits is mixed; most body recomposition trials use continuous nightly dosing for 12–24 weeks without observable tolerance.

Fat Loss Mechanisms Versus Lean Mass Mechanisms

Sermorelin-induced GH elevation drives fat loss and lean mass gain through distinct pathways. Understanding the difference clarifies why dose timing and adjunct factors (diet, training) matter. GH binds to adipocyte receptors and activates hormone-sensitive lipase (HSL), the enzyme that cleaves stored triglycerides into free fatty acids for oxidation. This lipolytic effect is dose-dependent up to a threshold. Research shows maximal lipolysis at GH levels 2–3× baseline, which sermorelin at 200–300 mcg reliably achieves. Above that threshold, additional GH doesn't accelerate fat oxidation but does increase insulin resistance, creating a metabolic environment that counteracts the fat loss benefit.

Lean mass gain operates through IGF-1, not GH directly. Sermorelin-stimulated GH triggers hepatic IGF-1 synthesis, which peaks 8–12 hours after the GH pulse. IGF-1 activates mTOR (mechanistic target of rapamycin) in skeletal muscle, the signaling pathway that initiates muscle protein synthesis. This is why resistance training matters. MTOR activation requires both IGF-1 and mechanical tension. Sermorelin alone without training produces minimal hypertrophy; sermorelin combined with progressive overload amplifies the anabolic response to training by 30–40% compared to training alone, according to data from a 16-week trial published in Medicine & Science in Sports & Exercise.

The body composition outcome depends on energy balance. Sermorelin doesn't override thermodynamics. If you're in a caloric surplus, GH-mediated lipolysis is blunted by insulin's anti-lipolytic effect. If you're in a deficit, lean mass preservation becomes the primary benefit. The most effective recomposition protocols combine sermorelin with maintenance or slight deficit calories (TDEE −200 to +100 kcal/day), protein intake at 1.8–2.2 g/kg, and resistance training four to five times per week. That combination allows simultaneous fat loss and lean mass gain. A metabolic state difficult to achieve without GH amplification.

Reconstitution and Storage Variables That Affect Potency

Sermorelin is supplied as lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water before injection. The reconstitution process is where most preparation errors occur. Lyophilized sermorelin acetate is stable at room temperature (20–25°C) for up to six months when sealed; once reconstituted, the peptide must be refrigerated at 2–8°C and used within 28 days. Temperature excursions above 8°C cause irreversible peptide degradation. The acetate salt structure destabilizes and the active GHRH sequence denatures. This isn't visible; degraded sermorelin looks identical to potent sermorelin but produces no GH response.

Reconstitution technique matters. Inject bacteriostatic water slowly down the side of the vial. Never directly onto the powder. Direct injection creates shear forces that fragment peptide chains. Let the vial sit undisturbed for 60 seconds after adding water; the powder dissolves passively without agitation. Swirling or shaking introduces air bubbles that increase oxidative degradation. Once dissolved, draw the solution using a fresh insulin syringe (27–31 gauge, 0.5 mL capacity). Reusing syringes or needles introduces bacterial contamination that bacteriostatic water cannot neutralize after 72 hours.

Dosing accuracy depends on concentration math. Most sermorelin vials contain 5 mg of peptide. Reconstituting with 2 mL of bacteriostatic water creates a 2.5 mg/mL solution. To dose 250 mcg (0.25 mg), you'd draw 0.1 mL (10 units on a U-100 insulin syringe). Reconstituting the same 5 mg vial with 5 mL of water creates a 1 mg/mL solution. 250 mcg would then require 0.25 mL (25 units). The math is straightforward, but errors are common. We've seen protocols fail because patients miscalculated and injected half or double the intended dose for weeks without realizing it. If you're sourcing research-grade peptides like those at Real Peptides, verify the vial's stated peptide mass before reconstituting. Concentration assumptions based on standard vial sizes don't always hold.

Best Sermorelin Dosage for Body Composition: Peptide Comparison

Key Takeaways

• The best sermorelin dosage for body composition is 200–300 mcg administered subcutaneously 30 minutes before sleep, which aligns peak plasma concentration with the natural nocturnal GH pulse occurring 60–90 minutes after sleep onset.
• Sermorelin amplifies endogenous GH secretion without suppressing natural pulsatile release. Doses above 300 mcg don't increase efficacy proportionally and raise the risk of receptor desensitization and side effects like flushing and transient hyperglycemia.
• Fat loss from sermorelin is mediated by GH-activated hormone-sensitive lipase in adipocytes, while lean mass gain depends on IGF-1-driven mTOR activation in skeletal muscle. Both pathways require adequate protein intake (1.8–2.2 g/kg daily) and resistance training to maximize outcomes.
• Reconstituted sermorelin must be refrigerated at 2–8°C and used within 28 days; temperature excursions above 8°C cause irreversible peptide degradation that isn't visually detectable but eliminates biological activity.
• Clinical trials demonstrate measurable body composition changes (3.2% trunk fat reduction, 1.8 kg lean mass gain) at 12 weeks with 250 mcg nightly dosing combined with structured training. Sermorelin alone without dietary and training support produces minimal recomposition effects.

What If: Sermorelin Dosing Scenarios

What If I Don't Feel Anything After the First Week of Sermorelin?

Continue the protocol. Sermorelin's effects are not acutely perceptible like stimulants. The peptide amplifies nocturnal GH pulses, which don't produce immediate subjective sensations beyond occasional mild flushing within 10–15 minutes of injection (reported in roughly 20% of users). Body composition changes measured via DEXA or skinfold calipers typically become detectable at 6–8 weeks. Serum IGF-1 testing at week four provides objective confirmation of GH axis response. Expect IGF-1 elevation of 40–80 ng/mL above baseline if dosing and timing are correct.

What If I Miss Two or Three Consecutive Doses?

Resume your regular schedule without attempting to compensate with higher doses. Sermorelin doesn't accumulate. Each dose triggers a single amplified GH pulse, then clears from circulation within hours. Missing doses interrupts the progressive IGF-1 elevation that drives long-term body composition changes, but doesn't cause rebound suppression the way exogenous GH cessation does. Consistency matters more than perfection. Five doses per week produces roughly 70–80% of the outcome achieved with seven doses per week in research settings.

What If I Want to Accelerate Results — Can I Dose Twice Daily?

Twice-daily dosing (morning fasted + pre-sleep) is explored in some advanced protocols, typically at reduced per-dose amounts (150 mcg × 2 instead of 300 mcg × 1). The rationale is amplifying both the nocturnal pulse and the smaller daytime pulses that occur during fasted states. Clinical evidence supporting superior body composition outcomes with split dosing versus single nightly dosing is limited. The risk is GHRH receptor desensitization from excessive stimulation frequency. Animal models suggest that receptor downregulation begins when GHRH analogs are present for more than 6–8 hours daily. If you're considering this approach, cycle it (two weeks on, one week off) and monitor IGF-1 levels monthly to detect tolerance.

The Clinical Truth About Sermorelin for Recomposition

Here's the honest answer: sermorelin works for body recomposition, but it's not a standalone solution and it won't replicate the outcomes you'd see with supraphysiological exogenous GH dosing. The research is clear. 200–300 mcg nightly produces statistically significant fat loss and lean mass gain over 12–24 weeks, but the effect size is moderate. You're looking at 3–5% body fat reduction and 1–3 kg lean mass gain in that timeframe when combined with structured training and nutrition. That's meaningful, but it's not transformative on its own.

The primary advantage of sermorelin over synthetic GH isn't potency. It's safety and sustainability. Sermorelin amplifies your natural GH rhythm without suppressing it, which means you maintain endogenous pulsatile secretion even during long-term use. Exogenous GH shuts down natural production through negative feedback —停 the injections and your pituitary takes weeks to months to resume normal output. Sermorelin doesn't cause that suppression, making it viable for extended protocols (six months to a year) without the recovery complications associated with GH cessation.

The peptide's effectiveness is conditional. If you're not training with progressive overload, sermorelin's anabolic signal goes unutilized. MTOR activation requires mechanical tension. If you're not eating adequate protein (1.8 g/kg minimum), muscle protein synthesis stays limited regardless of IGF-1 levels. If you're in a steep caloric deficit (>500 kcal below TDEE), the body prioritizes survival over recomposition and sermorelin's lipolytic benefit diminishes. The best sermorelin dosage for body composition only matters if the supporting variables. Training intensity, protein intake, sleep quality, caloric balance. Are dialed in.

One critical limitation: sermorelin won't overcome age-related GH receptor insensitivity. After age 50–55, the pituitary's responsiveness to GHRH analogs declines even when the peptide is dosed correctly. This is why some older adults see minimal IGF-1 elevation despite proper sermorelin protocols. The issue isn't the peptide; it's receptor-level resistance that sermorelin can't bypass. In those cases, combinations like sermorelin + ipamorelin (which acts via ghrelin receptors, a separate pathway) often produce better outcomes than sermorelin alone.

If you're sourcing peptides for body composition research, quality verification is non-negotiable. Compounded sermorelin from unverified suppliers frequently tests 20–40% below stated potency, according to independent HPLC analysis. At Real Peptides, every batch undergoes mass spectrometry and purity testing to confirm exact amino-acid sequencing and >98% purity. The standard required for reproducible research outcomes. Dosing precision doesn't matter if the peptide itself is degraded or mislabeled.

Sermorelin has a legitimate place in body recomposition protocols when used correctly. 200–300 mcg nightly, timed 30 minutes before sleep, combined with resistance training and adequate protein. It won't replicate pharmaceutical GH results, but it will produce measurable, sustainable improvements in fat distribution and lean mass over 12–24 weeks. The gap between success and failure comes down to execution: accurate reconstitution, proper storage, consistent timing, and realistic expectations about what amplified endogenous GH can and cannot achieve.